Alterity Therapeutics Ltd (ATHE) stock
ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
$1.86−0.09 (-4.85%)
Close on Nov 17, 2026Market cap $33.80MP/E –Yield –
Alterity Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Alterity Therapeutics's total assets was A$46.02M at Jun 30, 2026. For fiscal 2026 it was A$46.02M, down 0.0% from the year before. The highest annual figure on record is A$46.03M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | A$46.02M | -0.0% |
| FY2025 | Jun 30, 2025 | A$46.03M | +139.4% |
| FY2024 | Jun 30, 2024 | A$19.22M | -29.6% |
| FY2023 | Jun 30, 2023 | A$27.32M | -34.0% |
| FY2022 | Jun 30, 2022 | A$41.36M | +23.2% |
| FY2021 | Jun 30, 2021 | A$33.59M | +239.0% |
| FY2020 | Jun 30, 2020 | A$9.91M | -50.2% |
| FY2019 | Jun 30, 2019 | A$19.91M | +6.3% |
| FY2018 | Jun 30, 2018 | A$18.73M | -25.9% |
| FY2017 | Jun 30, 2017 | A$25.28M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | A$46.02M | +11.3% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | A$46.03M | +2.4% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | A$19.22M | -42.8% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | A$27.32M | -27.0% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | A$41.36M | +317.5% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | A$44.93M | +125.7% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | A$33.59M | +79.4% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | A$37.41M | +48.0% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | A$9.91M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | A$19.91M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | A$18.73M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | A$25.28M | – |
See a number that looks wrong?